{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:21:43Z","timestamp":1785417703788,"version":"3.56.0"},"reference-count":35,"publisher":"Royal College of Psychiatrists","issue":"2","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["BJPsych open"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec id=\"S2056472425109678_as1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Depressive and anxiety disorders often co-occur with insomnia, creating complex treatment challenges. Although clinical guidelines recommend psychotherapy as first-line treatment for these comorbid conditions, limited access to psychological services in primary healthcare facilities in China often leads to heavy reliance on pharmacological therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472425109678_as2\">\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To the appropriateness of psychotropic medications for patients with insomnia comorbid with depressive or anxiety disorders at primary healthcare facilities in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472425109678_as3\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This cross-sectional study included patients with documented diagnoses of insomnia comorbid depressive or anxiety disorders in 2022 at all 67 primary healthcare facilities in Dongcheng District, Beijing, China. The primary outcome was the prescribing rate of guideline-recommended psychotropic medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472425109678_as4\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 842 patients with insomnia and depressive disorders and 1014 patients with insomnia and anxiety disorders, over 90% received psychotropic medications. Benzodiazepines were the most frequently prescribed classes (55.9 and 69.6%), followed by non-benzodiazepine hypnotics (42.5 and 42.4%), whereas medications recommended by the guideline, including antidepressants with sedative effects, selective serotonin reuptake inhibitors and selective norepinephrine reuptake inhibitors, were used infrequently. Only 29.9% of patients with insomnia and depressive disorders and 11.5% of those with insomnia and anxiety disorders received guideline-recommended pharmacotherapy, with lower concordance among older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472425109678_as5\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Guideline-recommended pharmacotherapy for insomnia comorbid with depressive or anxiety disorders was rarely implemented at primary care in China. This highlights the need to facilitate evidence-based practices and improve management of comorbid mental health conditions, particularly for older adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1192\/bjo.2025.10967","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:05:02Z","timestamp":1770271502000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":1,"title":["Psychotropic medication prescribing for patients with insomnia comorbid with depressive or anxiety disorders in primary healthcare facilities in Beijing"],"prefix":"10.1192","volume":"12","author":[{"given":"Mengyuan","family":"Fu","sequence":"first","affiliation":[{"name":"International Research Center for Medicinal Administration, Peking University"},{"name":"Yale School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Li","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02v51f717","id-type":"ROR","asserted-by":"publisher"}],"name":"Peking University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02v51f717","id-type":"ROR","asserted-by":"publisher"}],"name":"Peking University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Gong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02v51f717","id-type":"ROR","asserted-by":"publisher"}],"name":"Peking University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuezhen","family":"Zhu","sequence":"additional","affiliation":[{"name":"Capital Medical University, Chaoyang District"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingtian","family":"Ding","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02v51f717","id-type":"ROR","asserted-by":"publisher"}],"name":"Peking University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Ling","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02v51f717","id-type":"ROR","asserted-by":"publisher"}],"name":"Peking University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"Dongcheng Health Service Management Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwen","family":"Shi","sequence":"additional","affiliation":[{"name":"International Research Center for Medicinal Administration, Peking University"},{"id":[{"id":"https:\/\/ror.org\/02v51f717","id-type":"ROR","asserted-by":"publisher"}],"name":"Peking University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1290-3827","authenticated-orcid":false,"given":"Xiaodong","family":"Guan","sequence":"additional","affiliation":[{"name":"International Research Center for Medicinal Administration, Peking University"},{"id":[{"id":"https:\/\/ror.org\/02v51f717","id-type":"ROR","asserted-by":"publisher"}],"name":"Peking University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"S2056472425109678_ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-000850"},{"key":"S2056472425109678_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2022.104959"},{"key":"S2056472425109678_ref8","first-page":"324","article-title":"Chinese guideline for the diagnosis and treatment of adult insomnia (2017 edition)","volume":"51","year":"2018","journal-title":"Chin J Neurol"},{"key":"S2056472425109678_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00683-9"},{"key":"S2056472425109678_ref24","volume-title":"ATC\/DDD Index 2025","year":"2025"},{"key":"S2056472425109678_ref26","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12594"},{"key":"S2056472425109678_ref30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2051"},{"key":"S2056472425109678_ref21","volume-title":"International Statistical Classification of Diseases and Related Health Problems 10th Revision","year":"2019"},{"key":"S2056472425109678_ref31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-191"},{"key":"S2056472425109678_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.08.017"},{"key":"S2056472425109678_ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0735-3"},{"key":"S2056472425109678_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14170"},{"key":"S2056472425109678_ref4","doi-asserted-by":"publisher","DOI":"10.1002\/da.20467"},{"key":"S2056472425109678_ref32","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13017"},{"key":"S2056472425109678_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"S2056472425109678_ref9","doi-asserted-by":"publisher","DOI":"10.7326\/M22-2056"},{"key":"S2056472425109678_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.09.032"},{"key":"S2056472425109678_ref19","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2021.0561"},{"key":"S2056472425109678_ref5","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51200"},{"key":"S2056472425109678_ref22","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2024.20"},{"key":"S2056472425109678_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31888-9"},{"key":"S2056472425109678_ref15","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13013tx8c"},{"key":"S2056472425109678_ref35","first-page":"h1232","article-title":"India\u2019s health ministry bans pioglitazone, metamizole, and flupentixol-melitracen","volume":"350","author":"Bhaumik","year":"2015","journal-title":"BMJ"},{"key":"S2056472425109678_ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.0044"},{"key":"S2056472425109678_ref25","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2175"},{"key":"S2056472425109678_ref27","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18372"},{"key":"S2056472425109678_ref18","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0903"},{"key":"S2056472425109678_ref16","volume-title":"Depression in Adults: Treatment and Management","year":"2022"},{"key":"S2056472425109678_ref10","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2022.2086295"},{"key":"S2056472425109678_ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-15-30"},{"key":"S2056472425109678_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2022.09.007"},{"key":"S2056472425109678_ref7","first-page":"564","article-title":"Expert consensus on the diagnosis and treatment of insomnia with depression and anxiety in Chinese adults","volume":"53","year":"2020","journal-title":"J Neurol"},{"key":"S2056472425109678_ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5205"},{"key":"S2056472425109678_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101583"},{"key":"S2056472425109678_ref23","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.2.229"}],"container-title":["BJPsych Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2056472425109678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:05:03Z","timestamp":1770271503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2056472425109678\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["S2056472425109678"],"URL":"https:\/\/doi.org\/10.1192\/bjo.2025.10967","relation":{},"ISSN":["2056-4724"],"issn-type":[{"value":"2056-4724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e55"}}